Poly(ethyleneimine) functionalized carbon nanotubes as efficient nano-vector for transfecting mesenchymal stem cells

Colloids and Surfaces B: Biointerfaces

Volumn 122, Issue , 2014, Pages 115-125

  Moradian, Hanieh ^a,b   Fasehee, Hamidreza ^a   Keshvari, Hamid ^b   Faghihi, Shahab ^a  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Gene delivery system; Mesenchymal stem cells; Multi walled carbon nanotubes; Polyethyleneimine; Transfection efficiency

Indexed keywords

BINDING ENERGY; BONE; CELL CULTURE; CHITOSAN; CONTROLLED DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; EFFICIENCY; ELECTROPHORESIS; GENE TRANSFER; GENES; MOLECULAR BIOLOGY; NANOTUBES; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; POLYETHYLENES; PROTEINS; STEM CELLS; SUBSTRATES; TARGETED DRUG DELIVERY;

BONE MARROW MESENCHYMAL STEM CELLS; ENHANCED GREEN FLUORESCENT PROTEIN; FUNCTIONALIZED CARBON NANOTUBES; GENE DELIVERY SYSTEMS; MESENCHYMAL STEM CELL; POLYETHYLENEIMINE; TRANSFECTION EFFICIENCY; ZETA POTENTIAL MEASUREMENTS;

MULTIWALLED CARBON NANOTUBES (MWCN);

CHITOSAN; DNA; MULTI WALLED NANOTUBE; POLYETHYLENEIMINE; ENHANCED GREEN FLUORESCENT PROTEIN; CARBON NANOTUBE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHEMICAL BINDING; CONTROLLED STUDY; CYTOCHEMISTRY; EGFP GENE; FLOW CYTOMETRY; GENE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MESENCHYMAL STEM CELL; MTT ASSAY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ZETA POTENTIAL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL TRANSPORT; CELL VIABILITY; COVALENT BOND; CYTOTOXICITY ASSAY; DNA BINDING; MALE; REPORTER GENE; ANIMAL; CHEMISTRY; CYTOLOGY; HEK293 CELL LINE; HUMAN; MESENCHYMAL STROMA CELL; WISTAR RAT;

ANIMALS; ELECTROPHORESIS, AGAR GEL; HEK293 CELLS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; NANOTUBES, CARBON; POLYETHYLENEIMINE; RATS; RATS, WISTAR; TRANSFECTION;

EID: 84904335197     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.06.056     Document Type: Article

References (96)

1. Segura T., Shea L.D. Materials for non-viral gene delivery. Annu. Rev. Mater. Res. 2001, 31(1):25-46.
2. Wong S.Y., Pelet J.M., Putnam D. Polymer systems for gene delivery-past, present, and future. Progr. Polym. Sci. 2007, 32(8-9):799-837.
3. Liau G., Su E.J., Dixon K.D. Clinical efforts to modulate angiogenesis in the adult: gene therapy versus conventional approaches. Drug Discov. Today 2001, 6(13):689-697.
4. Fischer A., Hacein-Bey-Abina S., Cavazzana-Calvo M. Gene therapy of primary T cell immunodeficiencies. Gene 2013, 525(2):170-173.
5. Huang S., Kamihira M. Development of hybrid viral vectors for gene therapy. Biotechnol. Adv. 2013, 31(2):208-223.
6. Wu T.-L., Zhou D. Viral delivery for gene therapy against cell movement in cancer. Adv. Drug Deliv. Rev. 2011, 63(8):671-677.
7. Selvam S., et al. Current status of gene delivery and gene therapy in lacrimal gland using viral vectors. Adv. Drug Deliv. Rev. 2006, 58(11):1243-1257.
8. Davis M.E. Non-viral gene delivery systems. Curr. Opin. Biotechnol. 2002, 13(2):128-131.
9. Mastrobattista E., et al. Nonviral gene delivery systems: From simple transfection agents to artificial viruses. Drug Discov. Today: Technol. 2005, 2(1):103-109.
10. Yamamoto M., Tabata Y. Tissue engineering by modulated gene delivery. Adv. Drug Deliv. Rev. 2006, 58(4):535-554.
11. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2012, 64(Supplement(0)):61-71.
12. Park T.G., Jeong J.H., Kim S.W. Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev. 2006, 58(4):467-486.
13. Dang J.M., Leong K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 2006, 58(4):487-499.
14. Pouton C.W., Seymour L.W. Key issues in non-viral gene delivery. Adv. Drug Deliv. Rev. 1998, 34(1):3-19.
15. Liu L., et al. Extracellular signal-regulated kinase1/2 activated by fluid shear stress promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells through novel signaling pathways. Int. J. Biochem. Cell Biol. 2011, 43(11):1591-1601.
16. Salasznyk R.M., et al. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp. Cell Res. 2007, 313(1):22-37.
17. Hess K., et al. TNFα promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-(B signaling pathway. Bone 2009, 45(2):367-376.
18. Liu S.Q., et al. Biomimetic hydrogels for chondrogenic differentiation of human mesenchymal stem cells to neocartilage. Biomaterials 2010, 31(28):7298-7307.
19. Danišovič Ľ., Varga I., Polák Š. Growth factors and chondrogenic differentiation of mesenchymal stem cells. Tissue Cell 2012, 44(2):69-73.
20. Liu J.-L., et al. MicroRNA 16 enhances differentiation of human bone marrow mesenchymal stem cells in a cardiac niche toward myogenic phenotypes in vitro. Life Sci. 2012, 90(25-26):1020-1026.
21. Santa María L., Rojas C.V., Minguell J.J. Signals from damaged but not undamaged skeletal muscle induce myogenic differentiation of rat bone-marrow-derived mesenchymal stem cells. Exp. Cell Res. 2004, 300(2):418-426.
22. Lu H., et al. Effect of cell density on adipogenic differentiation of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2009, 381(3):322-327.
23. Kang J.W., et al. The effects of cyclin-dependent kinase inhibitors on adipogenic differentiation of human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2008, 366(3):624-630.
24. Chen Y., et al. Mesenchymal stem cells: A promising candidate in regenerative medicine. Int. J. Biochem. Cell Biol. 2008, 40(5):815-820.
25. Deans R.J., Moseley A.B. Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 2000, 28(8):875-884.
26. Hamm A., et al. Efficient transfection method for primary cells. Tissue Eng. 2002, 8(2):235-245.
27. McMahon J.M., et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev. 2006, 15(1):87-96.
28. Hoelters J., et al. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J. Gene Med. 2005, 7(6):718-728.
29. Dass C.R. Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo. J. Pharm. Pharmacol. 2002, 54(5):593-601.
30. Ahn H.H., et al. DNA/PEI nano-particles for gene delivery of rat bone marrow stem cells. Colloids Surf. A: Physicochem. Eng. Aspects 2008, 313-314(0):116-120.
31. Ahn H.H., et al. Polyethyleneimine-mediated gene delivery into human adipose derived stem cells. Biomaterials 2008, 29(15):2415-2422.
32. Luten J., et al. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Control. Release 2008, 126(2):97-110.
33. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem. Rev. 2009, 109(2):259-302.
34. Gwak S.J., Kim B.S. Poly(lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimine. Biotechnol. Lett. 2008, 30(7):1177-1182.
35. Uchimura E., et al. Method for reverse transfection using gold colloid as a nano-scaffold. J. Biosci. Bioeng. 2007, 103(1):101-103.
36. Gonzalez-McQuire R., et al. Coating of human mesenchymal cells in 3D culture with bioinorganic nanoparticles promotes osteoblastic differentiation and gene transfection. Adv. Mater. 2007, 19(17):2236-2240.
37. Park S., et al. Carbon nanosyringe array as a platform for intracellular delivery. Nano Lett. 2009, 9(4):1325-1329.
38. Bianco A., Kostarelos K., Prato M. Applications of carbon nanotubes in drug delivery. Curr. Opin. Chem. Biol. 2005, 9(6):674-679.
39. Dumortier H., et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett. 2006, 6(7):1522-1528.
40. Pantarotto D., et al. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. (Camb.) 2004, (1):16-17.
41. Liu Z., et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008, 68(16):6652-6660.
42. Carbon nanotubes in cancer therapy and drug delivery. J. Drug Deliv. 2012, 2012:837327. 10.1155/2012/837327.
43. Pantarotto D., et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew. Chem. Int. Ed. 2004, 43(39):5242-5246.
44. Qin W., et al. Improved GFP gene transfection mediated by polyamidoamine dendrimer-functionalized multi-walled carbon nanotubes with high biocompatibility. Colloids Surf. B Biointerfaces 2011, 84(1):206-213.
45. Harrison B.S., Atala A. Carbon nanotube applications for tissue engineering. Biomaterials 2007, 28(2):344-353.
46. Pumera M. Carbon nanotube biosensors based on electrochemical detection. Methods Mol. Biol. 2010, 625:205-212.
47. Kam N.W., Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J. Am. Chem. Soc. 2005, 127(16):6021-6026.
48. Lee H. Membrane penetration and curvature induced by single-walled carbon nanotubes: the effect of diameter, length, and concentration. Phys. Chem. Chem. Phys. 2013, 15(38):16334-16340.
49. Liu X., et al. Biocompatible multi-walled carbon nanotube-chitosan-folic acid nanoparticle hybrids as GFP gene delivery materials. Colloids Surf. B: Biointerfaces 2013, 111(0):224-231.
50. Pantarotto D., et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew. Chem. 2004, 116(39):5354-5358.
51. Yang K., et al. Polyamidoamine dendrimer-functionalized carbon nanotubes-mediated GFP gene transfection for HeLa cells: effects of different types of carbon nanotubes. J. Biomed. Mater. Res. A 2011, 99(2):231-239.
52. Liu X., et al. Biocompatible multi-walled carbon nanotube-chitosan-folic acid nanoparticle hybrids as GFP gene delivery materials. Colloids Surf. B Biointerfaces 2013, 111C:224-231.
53. Zhang B., et al. Characterization of and biomolecule immobilization on the biocompatible multi-walled carbon nanotubes generated by functionalization with polyamidoamine dendrimers. Colloids Surf. B Biointerfaces 2010, 80(1):18-25.
54. Skandani A.A., Zeineldin R., Al-Haik M. Effect of chirality and length on the penetrability of single-walled carbon nanotubes into lipid bilayer cell membranes. Langmuir 2012, 28(20):7872-7879.
55. Raffa V., et al. Can the properties of carbon nanotubes influence their internalization by living cells?. Carbon 2008, 46(12):1600-1610.
56. Lacerda L., et al. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv. Drug Deliv. Rev. 2006, 58(14):1460-1470.
57. Shvedova A.A., et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health A 2003, 66(20):1909-1926.
58. Pulskamp K., Diabate S., Krug H.F. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol. Lett. 2007, 168(1):58-74.
59. Worle-Knirsch J.M., Pulskamp K., Krug H.F. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006, 6(6):1261-1268.
60. Carrero-Sanchez J.C., et al. Biocompatibility and toxicological studies of carbon nanotubes doped with nitrogen. Nano Lett. 2006, 6(8):1609-1616.
61. Sayes C.M., et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol. Lett. 2006, 161(2):135-142.
62. Tang S., et al. Short- and long-term toxicities of multi-walled carbon nanotubes in vivo and in vitro. J. Appl. Toxicol. 2012, 32(11):900-912.
63. Ge C., et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(41):16968-16973.
64. Magrez A., et al. Cellular toxicity of carbon-based nanomaterials. Nano Lett. 2006, 6(6):1121-1125.
65. Tian F., et al. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol. In Vitro 2006, 20(7):1202-1212.
66. Ziegler K.J., et al. Controlled oxidative cutting of single-walled carbon nanotubes. J. Am. Chem. Soc. 2005, 127(5):1541-1547.
67. Rosca I.D., et al. Oxidation of multiwalled carbon nanotubes by nitric acid. Carbon 2005, 43(15):3124-3131.
68. Shen M., et al. Polyethyleneimine-mediated functionalization of multiwalled carbon nanotubes: synthesis, characterization, and in vitro toxicity assay. J. Phys. Chem. C 2009, 113(8):3150-3156.
69. Datsyuk V., et al. Chemical oxidation of multiwalled carbon nanotubes. Carbon 2008, 46(6):833-840.
70. Hu H., et al. Polyethyleneimine functionalized single-walled carbon nanotubes as a substrate for neuronal growth. J. Phys. Chem. B 2005, 109(10):4285-4289.
71. Hsu S.H., Ho T.T., Tseng T.C. Nanoparticle uptake and gene transfer efficiency for MSCs on chitosan and chitosan-hyaluronan substrates. Biomaterials 2012, 33(14):3639-3650.
72. Goyanes S., et al. Carboxylation treatment of multiwalled carbon nanotubes monitored by infrared and ultraviolet spectroscopies and scanning probe microscopy. Diamond Related Mater. 2007, 16(2):412-417.
73. Davis W.M., et al. Quantitative Fourier Transform Infrared spectroscopic investigation humic substance functional group composition. Chemosphere 1999, 38(12):2913-2928.
74. Zhu J., et al. Improving the dispersion and integration of single-walled carbon nanotubes in epoxy composites through functionalization. Nano Lett. 2003, 3(8):1107-1113.
75. 2 solar cells. Langmuir 2004, 20(22):9807-9810.
76. Liu L., et al. Reduction of solubilized multi-walled carbon nanotubes. Carbon 2003, 41(2):331-335.
77. Hu Y., et al. Construction of polyethyleneimine-β-cyclodextrin/pDNA multilayer structure for improved in situ gene transfection. Adv. Eng. Mater. 2010, 12(1-2):B18-B25.
78. Singh R., et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J. Am. Chem. Soc. 2005, 127(12):4388-4396.
79. Pack D.W., et al. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 2005, 4(7):581-593.
80. Storrie H., Mooney D.J. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv. Drug Deliv. Rev. 2006, 58(4):500-514.
81. Cheung W., et al. DNA and carbon nanotubes as medicine. Adv. Drug Deliv. Rev. 2010, 62(6):633-649.
82. Kam N.W.S., Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J. Am. Chem. Soc. 2005, 127(16):6021-6026.
83. Sanz V., et al. Optimising DNA binding to carbon nanotubes by non-covalent methods. Carbon 2011, 49(5):1775-1781.
84. Wang F., et al. Charge-compensated: semiconducting single-walled carbon nanotube thin film as an electrically configurable optical medium. Nat. Photon 2013, 7(6):459-465.
85. Mercer R., et al. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part. Fibre Toxicol. 2010, 7(1):1-11.
86. Carbone M.et al. Are PEI-coated SWCNTs conjugated with hepatitis A virus? A chemical study with SEM, Z-potential, EDXD and RT-PCR. Biomed. Mater. 2010, 5(3):35001.
87. Kojima M., et al. Dispersion of single-walled carbon nanotubes modified with poly-l-tyrosine in water. Nanoscale Res. Lett. 2011, 6(1):128.
88. Price B.K. Functionalizations and Biological Applications of Single-walled Carbon Nanotubes and Graphite Systems 2009, Doctoral Thesis, Rice University. http://hdl.handle.net/1911/61928.
89. Tchoul M.N., et al. Effect of mild nitric acid oxidation on dispersability: size, and structure of single-walled carbon nanotubes. Chem. Mater. 2007, 19(23):5765-5772.
90. Vigolo B., et al. Macroscopic fibers and ribbons of oriented carbon nanotubes. Science 2000, 290(5495):1331-1334.
91. Lee J.Y., et al. Electrophoretic and dynamic light scattering in evaluating dispersion and size distribution of single-walled carbon nanotubes. J. Nanosci. Nanotechnol. 2005, 5(7):1045-1049.
92. Characterization of multiwalled carbon nanotubes dispersing in water and association with biological effects. J. Nanomater. 2011, 2011.
93. Tierney E.G., et al. The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds. J. Control. Release 2012, 158(2):304-311.
94. Huang G.S., et al. Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. Biomaterials 2011, 32(29):6929-6945.
95. Kang B., et al. Cell response to carbon nanotubes: size-dependent intracellular uptake mechanism and subcellular fate. Small 2010, 6(21):2362-2366.
96. Bussy C., et al. Intracellular fate of carbon nanotubes inside murine macrophages: pH-dependent detachment of iron catalyst nanoparticles. Part. Fibre Toxicol. 2013, 10:24.